Facing the challenge of social anxiety disorder

@article{Westenberg1999FacingTC,
  title={Facing the challenge of social anxiety disorder},
  author={H. Westenberg},
  journal={European Neuropsychopharmacology},
  year={1999},
  volume={9},
  pages={s93-s99}
}
  • H. Westenberg
  • Published 1999
  • Medicine, Psychology
  • European Neuropsychopharmacology
  • Social anxiety disorder is at serious and prevalent disorder that leads to significant disability in the social and professional lives of patients. It is a chronic condition that frequently coexists with other psychiatric conditions such as depression or alcoholism. Pharmacotherapy with benzodiazepines, monoamine oxidase inhibitors and selective serotonin reuptake inhibitors (SSRIs) has been assessed. Alprazolam has modest efficacy, while a more robust response to clonazepam has been reported… CONTINUE READING
    19 Citations
    Mirtazapine in social anxiety disorder: a pilot study
    • 26
    Ketamine and neuroticism: a double-hit hypothesis of internalizing disorders
    • 2
    • PDF
    Mechanisms of comorbidity, continuity, and discontinuity in anxiety-related disorders.
    • 34
    • Highly Influenced
    • PDF
    The embarrassed brain : towards a neurobiology of generalized socal anxiety disorder
    Mirtazapine in social anxiety disorder: a pilot study

    References

    SHOWING 1-10 OF 30 REFERENCES
    Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.
    • 190
    Alcohol dependence and anxiety disorders: what is the relationship?
    • 356
    • PDF
    The impact of social phobia on quality of life
    • 198
    Social phobia. Comorbidity and morbidity in an epidemiologic sample.
    • 1,086
    The Zurich study
    • M. Degonda, J. Angst
    • Psychology, Medicine
    • European Archives of Psychiatry and Clinical Neuroscience
    • 2005
    • 29
    Social phobia in general health care: an unrecognised undertreated disabling disorder.
    • 198